Cartilage tissue engineering using resorbable scaffolds

Journal of Tissue Engineering and Regenerative Medicine

Volumn 1, Issue 6, 2007, Pages 411-416

  Rotter, Nicole ^a   Bücheler, Markus ^b   Haisch, Andreas ^c   Wollenberg, Barbara ^a   Lang, Stephan ^d  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Cartilage; Head and neck surgery; Scaffolds; Tissue engineering

Indexed keywords

COST EFFECTIVENESS; DISEASES; SCAFFOLDS (BIOLOGY); SURGERY;

AGING POPULATION; CARTILAGE TISSUE ENGINEERING; ECONOMIC COSTS; ENGINEERED CARTILAGE; HEAD AND NECK SURGERY; MULTI-MODAL; RESORBABLE; SOCIO-ECONOMICS; TISSUES ENGINEERINGS; TUMOR THERAPY;

CARTILAGE;

BIOMATERIAL;

ANIMAL; CARTILAGE; CHONDROPATHY; CULTURE TECHNIQUE; HUMAN; INSTRUMENTATION; METABOLISM; METHODOLOGY; REVIEW; TISSUE ENGINEERING; TISSUE SCAFFOLD;

ANIMALS; BIOCOMPATIBLE MATERIALS; CARTILAGE; CARTILAGE DISEASES; CELL CULTURE TECHNIQUES; HUMANS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 45849087713     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.52     Document Type: Review

References (47)

1. Armstrong CG, Mow VC. 1982; Variations in the intrinsic mechanical properties of human articular cartilage with age, degeneration, and water content. J Bone Joint Surg (Am) 64A: 88-94.
2. Aulthouse AL, Beck M, Griffey E, et al. 1989; Expression of the human chondrocyte phenotype in vitro. In vitro Cell Dev Biol 25: 659-668.
3. Bannwarth B, Dougados M. 2003; Cardiovascular thrombotic events and COX-2 inhibitors: results in patients with osteoarthritis receiving rofecoxib. J Rheumatol 30: 421-422.
4. Baragi VM, Renkiewicz RR, Jordan H, et al. 1995; Transplantation of transduced chondrocytes protects articular cartilage from interleukin 1-induced extracellular matrix degradation. J Clin Invest 96: 2454-2460.
5. Bartlett W, Skinner JA, Gooding CR, et al. 2005; Autologous chondrocyte implantation versus matrix-induced autologous chondrocyte implantation for osteochondral defects of the knee: a prospective, randomised study. J Bone Joint Surg Br 87: 640-645
6. Boyan BD, Hummert TW, Dean DD, et al. 1996; Role of material surfaces in regulating bone and cartilage cell response. Biomaterials 17: 137-146.
7. Brittberg M, Lindahl A, Nilsson A, et al. 1994; Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 331: 889-895.
8. Bujia J, Alsalameh S, Sittinger M, et al. 1994; Antigen presenting cell function of class II positive human nasal chondrocytes. Acta Otolaryngol (Stockh) 114: 75-79.
9. Cao Y, Rodriguez A, Vacanti M, et al. 1998; Comparative study of the use of poly(glycolic acid), calcium alginate and pluronics in the engineering of autologous porcine cartilage. J Biomater Sci Polym Ed 9: 475-487.
10. Cui YL, Qi AD, Liu WG, et al. 2003; Biomimetic surface modification of poly(L-lactic acid) with chitosan and its effects on articular chondrocytes in vitro. Biomaterials 24: 3859-3868.
11. Di Martino A, Sittinger M, Risbud MV. 2005; Chitosan: a versatile biopolymer for orthopaedic tissue-engineering. Biomaterials 26: 5983-5990.
12. Haisch A, Groger A, Gebert C, et al. 2005; Creating artificial perichondrium by polymer complex membrane macroencapsulation: immune protection and stabilization of subcutaneously transplanted tissue-engineered cartilage. Eur Arch Otorhinolaryngol 262: 338-344.
13. Haisch A, Wanjura F, Radke C, et al. 2004; Immunomodulation of tissue-engineered transplants: in vivo bone generation from methylprednisolone-stimulated chondrocytes. Eur Arch Otorhinolaryngol 261: 216-224.
14. Hutmacher DW. 2000; Scaffolds in tissue engineering bone and cartilage. Biomaterials 21: 2529-2543.
15. Ibusuki S, Fujii Y, Iwamoto Y, Matsuda T. 2003; Tissue-engineered cartilage using an injectable and in situ gelable thermoresponsive gelatin: fabrication and in vitro performance. Tissue Eng 9: 371-384.
16. Kieswetter K, Schwartz Z, Hummert TW, et al. 1996; Surface roughness modulates the local production of growth factors and cytokines by osteoblast-like MG-63 cells. J Biomed Mater Res 32: 55-63.
17. Langer R. 2000; Tissue engineering. Mol Ther 1: 12-15.
18. Langer R, Vacanti JP. 1993; Tissue engineering. Science 260: 920-926.
19. Lee JE, Kim SE, Kwon IC, et al. 2004; Effects of a chitosan scaffold containing TGF-β1 encapsulated chitosan microspheres on in vitro chondrocyte culture. Artif Organs 28: 829-839.
20. Ma Z, Gao C, Gong Y, et al. 2005; Cartilage tissue engineering PLLA scaffold with surface immobilized collagen and basic fibroblast growth factor. Biomaterials 26: 1253-1259.
21. Mahmoudifar N, Doran PM. 2005; Tissue engineering of human cartilage in bioreactors using single and composite cell-seeded scaffolds. Biotechnol Bioeng. 91: 338-55.
22. Marcacci M, Berruto M, Brocchetta D, et al. 2005; Articular cartilage engineering with hyalograft(R) C: 3-year clinical results. Clin Orthop Relat Res 435: 96-105.
23. Minuth WW, Sittinger M, Kloth S. 1998; Tissue engineering: generation of differentiated artificial tissues for biomedical applications. Cell Tissue Res 291: 1-11.
24. Minuth WW, Strehl R, Schumacher K. 2004; Tissue factory: conceptual design of a modular system for the in vitro generation of functional tissues. Tissue Eng 10: 285-294.
25. Miot S, Woodfield T, Daniels AU, et al. 2005; Effects of scaffold composition and architecture on human nasal chondrocyte redifferentiation and cartilaginous matrix deposition. Biomaterials 26: 2479-2489.
26. Mulligan RC. 1993; The basic science of gene therapy. Science 260: 926-32.
27. Nagata S. 1994; Modification of the stages in total reconstruction of the auricle: Part I. Grafting the three-dimensional costal cartilage framework for lobule-type microtia. Plast Reconstr Surg 93: 221-30; discussion, 267-268.
28. Ohara K, Nakamura K, Ohta E. 1994; Chest wall deformities and thoracic scoliosis after costal cartilage graft harvesting. Plast Reconstr Surg 93: 1030-1036.
29. Patwari P, Kurz B, Sandy JD, et al. 2000; Mannosamine inhibits aggrecanase-mediated changes in the physical properties and biochemical composition of articular cartilage. Arch Biochem Biophys 374: 79-85.
30. Pittenger MF, Mackay AM, Beck SC, et al. 1999; Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
31. Rettinger G. 1992; [Autogenous and allogeneic cartilage transplants in head and neck surgery (excluding middle ear and trachea)]. Eur Arch Otorhinolaryngol Suppl 1: 127-162.
32. Rim JS, Mynatt RL, Gawronska-Kozak B. 2005; Mesenchymal stem cells from the outer ear: a novel adult stem cell model system for the study of adipogenesis. FASEB J 19: 1205-1207.
33. Rotter N, Bonassar LJ, Tobias G, et al. 2002a; Age dependence of biochemical and biomechanical properties of tissue-engineered human septal cartilage. Biomaterials 23: 3087-3094.
34. Rotter N, Tobias G, Lebl M, et al. 2002b; Age-related changes in the composition and mechanical properties of human nasal cartilage. Arch Biochem Biophys 403: 132-140.
35. Rotter N, Ung F, Roy AK, et al. 2005; Role for interleukin 1α in the inhibition of chondrogenesis in autologous implants using polyglycolic acid-polylactic acid scaffolds. Tissue Eng 11: 192-200.
36. Roufosse CA, DirekzeNC, OttoWR, et al. 2004; Circulating mesenchymal stem cells. Int J Biochem Cell Biol 36: 585-597.
37. Shields KJ, Beckman MJ, Bowlin GL, et al. 2004; Mechanical properties and cellular proliferation of electrospun collagen type II. Tissue Eng 10: 1510-1517.
38. Silva RM, Silva GA, Coutinho OP, et al. 2004; Preparation and characterization in simulated body conditions of glutaraldehyde crosslinked chitosan membranes. J Mater Sci Mater Med 15: 1105-1112.
39. Silva SS, Santos MI, Coutinho OP, et al. 2005; Physical properties and biocompatibility of chitosan/soy blended membranes. J Mater Sci Mater Med 16: 575-579.
40. Strehl R, Tallheden T, Sjogren-Jansson E, et al. 2005; Long-term maintenance of human articular cartilage in culture for biomaterial testing. Biomaterials 26: 4540-4549.
41. Tessmar J, Kellner K, Schulz MB, et al. 2004; Toward the development of biomimetic polymers by protein immobilization: PEGylation of insulin as a model reaction. Tissue Eng 10: 441-453.
42. Thornton AJ, Alsberg E, Albertelli M, et al. 2004; Shapedefining scaffolds for minimally invasive tissue engineering. Transplantation 77: 1798-1803.
43. Vinatier C, Magne D, Weiss P, et al. 2005; A silanized hydroxypropyl methylcellulose hydrogel for the three-dimensional culture of chondrocytes. Biomaterials 6: 6643-51.
44. von der Mark K, Gauss B, von der Mark H, et al. 1977; Relationship between shape and type of collagen sythesized as chondrocytes lose their cartilage phenotype in culture. Nature 267: 531-532.
45. Vunjak-Novakovic G, Martin I, Obradovic B, et al. 1999; Bioreactor cultivation conditions modulate the composition and mechanical properties of tissue-engineered cartilage. J Orthop Res 17: 130-138.
46. Yanaga H, Koga M, Imai K, et al. 2004; Clinical application of biotechnically cultured autologous chondrocytes as novel graft material for nasal augmentation. Aesthetic Plast Surg 28: 212-221.
47. Yanaga H, Yanaga K, Imai K, et al. 2006; Clinical application of cultured autologous human auricular chondrocytes with autologous serum for craniofacial or nasal augmentation and repair. Plast Reconstr Surg 117: 2019-2030; discussion, 2031-2032.